Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Significance: Gene therapy has made significant strides in the treatment and even cure of single-gene defects. However, the maturation of this field will require more sophisticated vehicles capable of cell-selective delivery of large genetic payloads whose regulated expression will restore or enhance cellular functionality. High-capacity herpes simplex virus vectors have the potential to meet these challenges but have been limited by the need to preserve one particularly cytotoxic viral product, infected cell polypeptide 0, to maintain transgene transcriptional activity. Our study describes a vector design that solves this conundrum, thereby promising the near-term availability of viral vectors that can efficiently deliver large or multiple regulated transgenes to a diversity of cells without attendant cytotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501 · cited 2×
“blastoma gene family deregulates G(1) control causing immortalization and increased”
BackgroundTargeted disruption of the three Rb-related genes leads to loss of G 1 control and immortalization
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · cited 1×
“The disruption of the hDaxx–ATRX complex can cause genomic instability (39) whereas the loss of retinoblastoma family proteins dysregulates normal cell-cycle progression (40, 41).”
BackgroundDannenberg, J.-H., van Rossum, A., Schuijff, L., & te Riele, H. (2000) · Genes & Development · doi:10.1101/gad.847700 · Cited by 413 · cited 1×
“The disruption of the hDaxx–ATRX complex can cause genomic instability (39) whereas the loss of retinoblastoma family proteins dysregulates normal cell-cycle progression (40, 41).”
BackgroundAllocca, M., Doria, M., Petrillo, M., Colella, P., Garcia-Hoyos, M., Gibbs, D., Kim, S. R., Maguire, A., Rex, T. S., Di Vicino, U., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34316 · Cited by 292
Monahan, P. E., Lothrop, C. D., Sun, J., Hirsch, M. L., Kafri, T., Kantor, B., Sarkar, R., Tillson, D. M., Elia, J. R., & Samulski, R. J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.170 · Cited by 125
Cited by
Viral vector‐based gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269
Gene Therapy Tools for Brain Diseases
Ingusci, S., Verlengia, G., Soukupova, M., Zucchini, S., & Simonato, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00724 · Cited by 158
Self-citationMiyagawa, Y., Verlengia, G., Reinhart, B., Han, F., Uchida, H., Zucchini, S., Goins, W. F., Simonato, M., Cohen, J. B., & Glorioso, J. C. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.06.001 · Cited by 23
Self-citationMoving toward a gene therapy for Huntington’s disease
Glorioso, J. C., Cohen, J. B., Carlisle, D. L., Munoz-Sanjuan, I., & Friedlander, R. M. (2015) · Gene Therapy · doi:10.1038/gt.2015.102 · Cited by 20
Self-citationOn the development of optical peripheral nerve interfaces
Anderson, H., & Weir, R. F. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.245461 · Cited by 14
“Herpes simplex viral vectors Herpes simplex virus is an enveloped dsDNA virus, capable of carrying a payload up to 16.5 kb (Miyagawa et al., 2015), and has been used for viral delivery to DRG neurons following peripheral innoculation for short term expression (2–4 weeks) in sensory fibers (Goss et…”
MethodInfluential
Metadata
- Authors
- Miyagawa, Y., Marino, P., Verlengia, G., Uchida, H., Goins, W. F., Yokota, S., Geller, D. A., Yoshida, O., Mester, J., Cohen, J. B., & Glorioso, J. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2015-03-16
- Volume
- 112
- Issue
- 13
- Pages
- E1632-41
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1984105546
- Cited by
- 80
- References
- 5
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. https://app.cochat.ai/papers/10.1073/pnas.1423556112
- The paper
- Miyagawa, Y., Marino, P., Verlengia, G., Uchida, H., Goins, W. F., Yokota, S., Geller, D. A., Yoshida, O., Mester, J., Cohen, J. B., & Glorioso, J. C. (2015). Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1423556112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.